Compare LEU & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEU | LMAT |
|---|---|---|
| Founded | 1998 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | 1998 | 2006 |
| Metric | LEU | LMAT |
|---|---|---|
| Price | $81.73 | $73.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 8 |
| Target Price | ★ $180.00 | $99.29 |
| AVG Volume (30 Days) | ★ 719.9K | 229.2K |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 1.34% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | ★ 2.63 | 2.07 |
| Revenue | $193,000,000.00 | ★ $249,602,000.00 |
| Revenue This Year | $6.14 | $10.59 |
| Revenue Next Year | $7.34 | $9.93 |
| P/E Ratio | ★ $34.09 | $36.15 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $84.86 | $73.69 |
| 52 Week High | $345.60 | $118.01 |
| Indicator | LEU | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 32.23 | 34.16 |
| Support Level | N/A | N/A |
| Resistance Level | $117.45 | $83.68 |
| Average True Range (ATR) | 8.27 | 2.64 |
| MACD | -0.54 | -0.81 |
| Stochastic Oscillator | 0.79 | 1.74 |
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.